Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMD.

Isabella D BaurMarta S FigueroaLars-Olof HattenbachCarlos E PavesioMajid AnderesiRobert SchmouderYu ChenMarc D de Smet

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2021)

IOI may precede RV or RO in some patients treated with brolucizumab.

Keyphrases

end stage renal disease
ejection fraction
age related macular degeneration
chronic kidney disease
mycobacterium tuberculosis
newly diagnosed
oxidative stress
prognostic factors
patient reported outcomes
patient reported